Don’t Add Anakinra to Your COVID-19 Treatment Protocol
February 2023
You’ll hear about anakinra (Kineret) to treat patients admitted with COVID-19...due to a new emergency use authorization.
This IL-1 inhibitor is now authorized for certain adults with SARS-CoV-2 at risk of progressing to severe respiratory failure.
These are patients on low- or high-flow supplemental oxygen...but NOT noninvasive or mechanical ventilation.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote